Exploring how cytokines signal in the immune system
Shedding new light on cytokine signaling through molecular engineering
This study is looking at how certain proteins in our immune system help us fight infections and cancer, with the goal of finding new ways to treat these conditions and improve health for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11065516 on NIH RePORTER |
What this research studies
This research investigates the role of cytokine signaling in the immune response to infections and cancer. It focuses on understanding how different cytokines influence the innate and adaptive immune systems, which are crucial for fighting diseases. By utilizing advanced protein engineering techniques, the research aims to uncover new therapeutic targets and improve our understanding of immune function. Patients may benefit from insights that could lead to innovative treatments for various conditions related to immune response.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with immune system disorders, infections, or cancers that may benefit from improved cytokine signaling.
Not a fit: Patients with conditions unrelated to immune response or cytokine signaling may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that enhance the immune response against infections and cancers.
How similar studies have performed: Previous research has shown promise in manipulating cytokine signaling for therapeutic purposes, indicating potential success for this approach.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Mendoza, Juan Luis — University of Chicago
- Study coordinator: Mendoza, Juan Luis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.